Spain Updates Authorized Cannabis Cultivation Map with Focus on Medical Production

Spain's medicines regulatory agency (AEMPS) has updated its cannabis cultivation authorization list to 22 permits distributed among 20 entities, marking a significant shift toward medical production and process validation over research operations. The regulatory framework now prioritizes therapeutic applications, though transparency gaps remain regarding individual production volumes and patient access metrics. This evolution reflects growing integration of cannabis into Spain's medical system, though advocates note the registry lacks detailed data on actual patient reach and treatment outcomes. The changes underscore Spain's commitment to structured medical cannabis regulation while highlighting the need for enhanced monitoring mechanisms. For patients and healthcare providers, these authorizations represent expanded potential for standardized, regulated cannabis-derived medicines.